Question 1

Am I eligible for this trial based on my current treatment and symptoms?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis clinical trial (NCT07389590). Contact the study team or your healthcare provider for specific answers.

Question 2

How does ublituximab compare to my current treatment with ocrelizumab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis clinical trial (NCT07389590). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of switching to ublituximab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis clinical trial (NCT07389590). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my treatment schedule change if I participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis clinical trial (NCT07389590). Contact the study team or your healthcare provider for specific answers.

Question 5

What tests or monitoring will I need to undergo during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis clinical trial (NCT07389590). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience worsening symptoms during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis clinical trial (NCT07389590). Contact the study team or your healthcare provider for specific answers.

What this study is about